-
The characteristics of the study population are summarized in Table 1. A total of 3,079 children and adolescents with a median age of 11.4 years (IQR, 8.9–13.8 years) were included in our analysis, among whom 49.1% were girls. The majority of the participants was Han Chinese (97.7%) and lived in urban areas (84.4%). Median serum folate and vitamin B12 concentrations were 6.9 ng/mL (IQR, 4.7–9.7 ng/mL) and 554.4 pg/mL (IQR, 405.8–729.1 pg/mL), respectively. General obesity was observed in 405 participants (13.2%) and abdominal obesity was observed in 607 participants (19.7%). Generally, compared to participants without obesity, those with obesity were more likely to be boys, younger, urban residents, passive smokers, and exhibited higher hs-CRP and eGFR levels but lower vitamin B12 concentrations (Table 1).
Table 1. Characteristics of the participants residing in Jiangsu Province, China from 2016 to 2017
Characteristics Total population
(n = 3,079)General obesity P-value No (n = 2,674, 86.8) Yes (n = 405, 13.2) Age (years) 11.4 (8.9, 13.8) 11.5 (8.9, 13.9) 10.4 (8.6, 13) < 0.001 Sex, n (%) < 0.001 Male 1,567 (50.9) 1,293 (48.4) 274 (67.7) Female 1,512 (49.1) 1,381 (51.6) 131 (32.3) Age group (years), n (%) 0.005 6–11 1,749 (56.8) 1,493 (55.8) 256 (63.2) 12–17 1,330 (43.2) 1,181 (44.2) 149 (36.8) Region, n (%) 0.003 Urban 2,599 (84.4) 2,237 (83.7) 362 (89.4) Rural 480 (15.6) 437 (16.3) 43 (10.6) Ethnicity, n (%) 0.521 Han ethnicity 3,009 (97.7) 2,615 (97.8) 394 (97.3) Ethnicity other than Han 70 (2.3) 59 (2.2) 11 (2.7) Lifestyle Total energy intake (kcal/day) 1,884 (1439.7, 2548.9) 1880.6 (1441.1, 2547.8) 1907.7 (1429.4, 2572.2) 0.949 Multivitamin or B-vitamin
supplements (yes), n (%)23 (0.7) 22 (0.8) 1 (0.2) 0.210 MVPA (minutes/day) 20 (8.6, 40) 20 (8.6, 40) 20 (7.9, 38.6) 0.350 Passive smoking, n (%) 0.046 Never 1,803 (58.6) 1,576 (58.9) 277 (56.0) Not daily 1,023 (33.2) 891 (33.1) 132 (32.6) Every day 253 (8.2) 207 (7.7) 46 (11.4) Alcohol consumption, n (%) 0.425 Never 2,776 (90.2) 2,404 (89.9) 372 (91.9) Former 222 (7.2) 199 (7.4) 23 (5.7) Current 81 (2.6) 71 (2.7) 10 (2.5) Anthropometrics Weight (kg) 42.0 (30.1, 54.5) 40.1 (29.1, 52.4) 56.7 (42, 74) < 0.001 Height (cm) 150.1 (135.2, 162.1) 150 (134.9, 162) 150.5 (137.7, 162.5) 0.160 BMI (kg/m2) 18.3 (16.0, 21.2) 17.6 (15.8, 20.0) 25.0 (22.0, 27.5) < 0.001 BMI-z 0.3 (−0.2, 1.0) 0.1 (−0.3, 0.7) 2.2 (1.8, 2.7) < 0.001 WC (cm) 63.4 (56.6, 71.2) 62.1 (55.8, 68.5) 79.5 (71.6, 88.1) < 0.001 WHtR 0.4 (0.4, 0.5) 0.4 (0.4, 0.5) 0.5 (0.5, 0.6) < 0.001 Abdominal obesity, n (%) 607 (19.7) 252 (9.4) 355 (87.7) < 0.001 Biochemistry Serum folate (ng/mL) 6.9 (4.7, 9.7) 6.9 (4.7, 9.8) 6.9 (5, 9.6) 0.812 Serum vitamin B12 (pg/mL) 554.4 (405.8, 729.1) 560 (408.4, 742.9) 524.7 (394.6, 676.9) 0.026 hs-CRP (mg/L) 0.3 (0.2, 0.8) 0.3 (0.2, 0.7) 0.9 (0.5, 2.2) < 0.001 eGFR (mL/min per 1.73 m2) 148.6 (135.2, 160.0) 148.0 (134.8, 159.3) 153.4 (139.1, 164) < 0.001 Note. Values are presented as median (interquartile range [IQR]) for continuous variables and n (%) for categorical variables. MVPA, total moderate-to-vigorous intensity physical activity; BMI, body mass index; BMI-z, BMI z-score; WC, waist circumference; WHtR, waist-to-height ratio; hs-CRP, high-sensitivity C-reactive protein; eGFR, estimated glomerular filtration rate. P-values were calculated using the Mann-Whitney U-test for continuous variables and the chi-square test for categorical variables. Table 2 shows the linear associations of serum folate and vitamin B12 levels with BMI, BMI-z, WC, and WHtR assessed using linear regression models. Serum vitamin B12 concentrations were inversely associated with BMI (β = −1.34, 95% CI = −1.66, −1.01, P < 0.001), BMI-z (β = −0.38, 95% CI = −0.48, −0.29, P < 0.001), WC (β = −4.50, 95% CI = −5.37, −3.63, P < 0.001) and WHtR (β = −0.023, 95% CI = −0.023, −0.018, P < 0.001) across all models. The generalized additive models demonstrated that the inverse associations of serum vitamin B12 with BMI and WC were almost roughly linear across the distribution of vitamin B12 values (Figure 2). No significant associations of serum folate with BMI, BMI-z, WC, and WHtR were identified in models 1 and 2. After additionally adjusting for serum vitamin B12 concentrations, serum folate was observed to be positively associated with WC (β = 0.80, 95% CI = 0.08, 1.52, P = 0.024) and WHtR (β = 0.004, 95% CI = 0.000, 0.009, P = 0.044). Further, the general additive model revealed a bell-shaped association between serum folate levels and BMI and an almost positive linear association between serum folate levels and WC (Figure 2). Because the association of vitamin B12 and folate with BMI z-scores was similar to that with BMI and the association with WHtR was similar to that with WC, further graphs on BMI z-scores and WHtR was not represented.
Table 2. Associations of serum folate and vitamin B12 concentrations with anthropometric indices among Chinese children and adolescents in Jiangsu Province, 2016–2017 (n = 3,079)
Micronutrient Model 1 Model 2 Model 3 Coefficient 95% Cl Coefficient 95% Cl Coefficient 95% Cl Serum folate (ng/mL) BMI −0.19 −0.45, 0.07 −0.23 −0.49, 0.03 0.09 −0.18, 0.35 BMI-z −0.06 −0.14, 0.01 −0.08 −0.15, 0.01 0.02 −0.06, 0.09 WC 0.39 −0.32, 1.10 −0.26 −0.96, 0.44 0.80 0.08, 1.52 WHtR 0.003 −0.001, 0.007 −0.001 −0.005, 0.003 0.004 0, 0.009 Serum vitamin B12 (pg/mL) BMI −0.83 −1.14, −0.53 −1.31 −1.61, −1.00 −1.34 −1.66, −1.01 BMI-z −0.24 −0.33, −0.15 −0.38 −0.47, −0.29 −0.38 −0.48, −0.29 WC −2.17 −3.00, −1.33 −4.23 −5.06, −3.39 −4.50 −5.37, −3.63 WHtR −0.011 −0.16, −0.006 −0.021 −0.026, −0.016 −0.023 −0.028, −0.018 Note. Model 1: adjusted for age, sex; Model 2: additionally adjusted for region, ethnicity, total energy intake, MVPA time, passive smoking status, alcohol consumption status, hs-CRP (log-transformed), eGFR (log-transformed), and multivitamin or B-vitamin supplement use. Model 3: additionally adjusted for vitamin B12(log-transformed) or serum folate (log-transformed) concentrations. MVPA, total moderate-to-vigorous intensity physical activity; BMI, Body mass index; BMI-z, BMI z-score; WC, waist circumference; WHtR, waist-to-height ratio; hs-CR, high-sensitivity C-reactive protein; eGFR, estimated glomerular filtration rate; CI,confidence interval. Serum folate and vitamin B12 were log-transformed. Figure 2. Dose-response curves with 95% confidence intervals (shaded areas) representing the associations of serum folate and vitamin B12 with BMI and WC. Associations were modeled using generalized additive models (n = 3,079). Models were adjusted for age, sex, region, ethnicity, total energy intake, MVPA time, multivitamin or B-vitamin supplements use, hs-CRP (log-transformed), eGFR (log-transformed), passive smoking status, alcohol consumption status, and vitamin B12 (log-transformed) or serum folate (log-transformed) concentrations. Density plots and rug plots indicate the distributions and density of log-transformed serum folate or vitamin B12 levels. Dotted lines denote the 10th, 50th, and 90th percentiles.
As shown in Table 3, serum vitamin B12 levels were inversely associated with general obesity (OR = 0.68, 95% CI = 0.59, 0.78, P < 0.001) and abdominal obesity (OR = 0.68, 95% CI = 0.60, 0.77, P < 0.001) after adjusting for all potential confounding factors. When compared with participants in the lowest quartile, those in the highest quartile of serum vitamin B12 concentration had 71% lower odds of general obesity (OR = 0.29, 95% CI = 0.20, 0.43, P < 0.001) and 64% lower odds of abdominal obesity (OR = 0.36, 95% CI = 0.26, 0.50, P < 0.001). When evaluated as continuous exposure, no associations were observed between serum folate concentration and the odds of general and abdominal obesity. However, when compared with participants in the lowest quartile, those in the second quartile of serum folate concentration exhibited 44% higher odds of general obesity (OR = 1.44, 95% CI = 1.03, 2.00, P = 0.032) after additionally adjusting for serum vitamin B12 concentrations.
Table 3. Multivariable associations of serum folate and vitamin B12 levels with odds of general obesity and abdominal obesity among children and adolescents in Jiangsu Province, from 2016 to 2017 (n = 3,079)
Variables Model 1 Model 2 Model 3 OR (95% CI) OR (95% CI) OR (95% CI) Serum folate General obesity Continuous 0.96 (0.85, 1.08) 0.92 (0.81, 1.05) 1.02 (0.89, 1.17) Q1 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) Q2 1.17 (0.86, 1.60) 1.26 (0.91, 1.72) 1.44 (1.03, 2.00) Q3 1.00 (0.72, 1.39) 1.03 (0.73, 1.46) 1.22 (0.86, 1.74) Q4 0.91 (0.64, 1.28) 0.84 (0.58, 1.21) 1.08 (0.74, 1.59) P-trend 0.348 0.163 0.941 Abdominal obesity Continuous 0.98 (0.88, 1.09) 0.90 (0.81, 1.01) 1.00 (0.89, 1.13) Q1 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) Q2 1.06 (0.82, 1.38) 1.05 (0.80, 1.39) 1.21 (0.91, 1.60) Q3 0.90 (0.68, 1.18) 0.82 (0.61, 1.10) 0.98 (0.72, 1.32) Q4 0.94 (0.71, 1.25) 0.79 (0.58, 1.07) 1.02 (0.74, 1.40) P-trend 0.426 0.047 0.685 Serum vitamin B12 General obesity Continuous 0.82 (0.73, 0.93) 0.68 (0.60, 0.78) 0.68 (0.59, 0.78) Q1 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) Q2 0.90 (0.67, 1.21) 0.72 (0.53, 0.99) 0.72 (0.52, 0.99) Q3 0.79 (0.58, 1.08) 0.61 (0.44, 0.86) 0.61 (0.43, 0.85) Q4 0.46 (0.32, 0.65) 0.29 (0.2, 0.43) 0.29 (0.20, 0.43) P-trend < 0.001 < 0.001 < 0.001 Abdominal obesity Continuous 0.83 (0.75, 0.92) 0.68 (0.61, 0.76) 0.68 (0.60, 0.77) Q1 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) Q2 0.86 (0.67, 1.11) 0.67 (0.51, 0.87) 0.67 (0.51, 0.88) Q3 0.83 (0.64, 1.08) 0.63 (0.47, 0.83) 0.63 (0.47, 0.85) Q4 0.56 (0.42, 0.75) 0.36 (0.26, 0.49) 0.36 (0.26, 0.50) P-trend < 0.001 < 0.001 < 0.001 Note. The quartiles of serum folate concentration were as follows: < 4.7 ng/mL (Q1), 4.7–6.8 (Q2), 6.9–9.6 (Q3), and ≥ 9.7 (Q4). The quartiles of serum vitamin B12 concentrations were as follows: < 405.4 pg/mL (Q1), 405.4–554.1 (Q2), 554.2–728.8 (Q3), and ≥ 728.9 (Q4). Model 1: adjusted for age, sex; Model 2: additionally adjusted for region, ethnicity, total energy intake, MVPA time, passive smoking status and alcohol consumption status, hs-CRP (log-transformed), eGFR (log-transformed) and multivitamin or B-vitamin supplements use; Model 3: additionally adjusted for vitamin B12 (log-transformed) or serum folate (log-transformed) concentrations. MVPA, total moderate-to-vigorous intensity physical activity; hs-CRP, high-sensitivity C-reactive protein; eGFR, estimated glomerular filtration rate; OR, odds ratio; CI, confidence interval. Serum folate and vitamin B12 levels were log-transformed and standardized by subtracting the mean and dividing it by the standard deviation. We further evaluated the potential interaction between serum concentrations of folate and vitamin B12 using logistic regression analysis (Table 4). Participants with high concentrations of both folate and vitamin B12 (the highest quartile for each vitamin) had lower odds of general (OR = 0.31, 95% CI = 0.19, 0.50, P < 0.001) and abdominal obesity (OR = 0.46, 95% CI = 0.31, 0.67, P < 0.001) compared with those with moderate levels of both vitamins. Conversely, low serum vitamin B12 concentrations in combination with high serum folate concentrations were positively associated with higher odds of abdominal obesity (OR = 2.06, 95% CI = 1.09, 3.91, P = 0.026). Higher odds of general obesity were observed only for low serum vitamin B12 concentrations in combination with moderate serum folate concentrations (OR = 1.63, 95% CI = 1.11, 2.40, P = 0.012). Additionally, we observed a trend towards reduced odds of general (P-trend < 0.001) and abdominal obesity (P-trend < 0.001) with increased serum folate and vitamin B12 levels (data not shown). Conversely, a trend toward indicating high odds of abdominal obesity was observed with increased serum folate levels accompanied by low vitamin B12 levels (P-trend = 0.001) (data not shown).
Table 4. Joint association of serum folate and vitamin B12 levels with general obesity and abdominal obesity among Chinese children and adolescents in Jiangsu Province, from 2016 to 2017 (n = 3,079)
Serum folate Serum vitamin B12 Low Moderate High General obesity Low 1.13 (0.74, 1.72) 0.80 (0.53, 1.21) 0.63 (0.27, 1.49) Moderate 1.63 (1.11, 2.40) 1.00 (ref.) 0.51 (0.34, 0.77) High 1.60 (0.75, 3.41) 0.93 (0.65, 1.34) 0.31 (0.19, 0.50) Abdominal obesity Low 1.43 (1.00, 2.03) 0.94 (0.66, 1.33) 0.77 (0.37, 1.59) Moderate 1.50 (1.07, 2.11) 1.00 (ref.) 0.60 (0.42, 0.85) High 2.06 (1.09, 3.91) 0.96 (0.70, 1.32) 0.46 (0.31, 0.67) Note. The categories “low” “moderate” and “high” serum folate levels were based to quartiles and defined as follows: ≤ 4.7 ng/mL (Q1), 4.8–9.7 ng/mL (Q2 and Q3) and > 9.8 ng/mL (Q4), respectively. The categories “low” “moderate” and “high” serum vitamin B12 levels were based to quartiles (Q) and defined as follows: ≤ 405.4 pg/mL (Q1), 405.4–728.7 ng/mL (Q2 and Q3) and > 728.8 ng/mL (Q4), respectively. Model adjusted for age, sex, region, ethnicity, total energy intake, MVPA time, multivitamin or B-vitamin supplement use, hs-CRP level (log-transformed), eGFR (log-transformed), passive smoking status, and alcohol consumption status.MVPA, total moderate-to-vigorous intensity physical activity; hs-CRP, high-sensitivity C-reactive protein; eGFR, estimated glomerular filtration rate.
doi: 10.3967/bes2024.028
Association of Serum Folate and Vitamin B12 Concentrations with Obesity in Chinese Children and Adolescents
-
Abstract:
Objective This study aimed to evaluate the associations of serum folate and/or vitamin B12 concentrations with obesity among Chinese children and adolescents. Methods A cross-sectional study was conducted including 3,079 Chinese children and adolescents, aged 6 to 17 years, from Jiangsu, China. Anthropometric indices, such as, children's body mass index (BMI), BMI z-scores, waist circumference, and waist-to-height ratio were utilized. Multivariable linear regression and generalized additive models were used to investigate the associations of serum folate and vitamin B12 levels with anthropometric indices and odds of obesity. Results We observed that serum vitamin B12 concentrations were inversely associated with all anthropometric indices and the odds of general obesity [odds ratio (OR) = 0.68; 95% confidence interval (CI) = 0.59, 0.78] and abdominal obesity (OR = 0.68; 95% CI = 0.60, 0.77). When compared to participants with both serum vitamin levels in the two middle quartiles, those with both serum folate and vitamin B12 levels in the highest quartile were less prone to general (OR = 0.31, 95% CI = 0.19, 0.50) or abdominal obesity (OR = 0.46, 95% CI = 0.31, 0.67). Conversely, participants with vitamin B12 levels in the lowest quartile alongside folate levels in the highest quartile had higher odds of abdominal obesity (OR = 2.06, 95% CI = 1.09, 3.91). Conclusion Higher serum vitamin B12 concentrations, but not serum folate concentrations, were associated with lower odds of childhood obesity. Children and adolescents with high levels of vitamin B12 and folate were less likely to be obese. -
Key words:
- Folate /
- Vitamin B12 /
- Childhood obesity /
- Micronutrient
This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the National Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention (protocol code: 2016-14; date of approval: January 2016). Informed consent was obtained from all the participants involved in the study.
注释:1) AUTHOR CONTRIBUTIONS: 2) Ethics Approval and Consent to Participate: -
Figure 2. Dose-response curves with 95% confidence intervals (shaded areas) representing the associations of serum folate and vitamin B12 with BMI and WC. Associations were modeled using generalized additive models (n = 3,079). Models were adjusted for age, sex, region, ethnicity, total energy intake, MVPA time, multivitamin or B-vitamin supplements use, hs-CRP (log-transformed), eGFR (log-transformed), passive smoking status, alcohol consumption status, and vitamin B12 (log-transformed) or serum folate (log-transformed) concentrations. Density plots and rug plots indicate the distributions and density of log-transformed serum folate or vitamin B12 levels. Dotted lines denote the 10th, 50th, and 90th percentiles.
MVPA, total moderate-to-vigorous intensity physical activity; BMI, body mass index; WC, waist circumference; hs-CRP, high-sensitivity C-reactive protein; eGFR, estimated glomerular filtration rate.
Table 1. Characteristics of the participants residing in Jiangsu Province, China from 2016 to 2017
Characteristics Total population
(n = 3,079)General obesity P-value No (n = 2,674, 86.8) Yes (n = 405, 13.2) Age (years) 11.4 (8.9, 13.8) 11.5 (8.9, 13.9) 10.4 (8.6, 13) < 0.001 Sex, n (%) < 0.001 Male 1,567 (50.9) 1,293 (48.4) 274 (67.7) Female 1,512 (49.1) 1,381 (51.6) 131 (32.3) Age group (years), n (%) 0.005 6–11 1,749 (56.8) 1,493 (55.8) 256 (63.2) 12–17 1,330 (43.2) 1,181 (44.2) 149 (36.8) Region, n (%) 0.003 Urban 2,599 (84.4) 2,237 (83.7) 362 (89.4) Rural 480 (15.6) 437 (16.3) 43 (10.6) Ethnicity, n (%) 0.521 Han ethnicity 3,009 (97.7) 2,615 (97.8) 394 (97.3) Ethnicity other than Han 70 (2.3) 59 (2.2) 11 (2.7) Lifestyle Total energy intake (kcal/day) 1,884 (1439.7, 2548.9) 1880.6 (1441.1, 2547.8) 1907.7 (1429.4, 2572.2) 0.949 Multivitamin or B-vitamin
supplements (yes), n (%)23 (0.7) 22 (0.8) 1 (0.2) 0.210 MVPA (minutes/day) 20 (8.6, 40) 20 (8.6, 40) 20 (7.9, 38.6) 0.350 Passive smoking, n (%) 0.046 Never 1,803 (58.6) 1,576 (58.9) 277 (56.0) Not daily 1,023 (33.2) 891 (33.1) 132 (32.6) Every day 253 (8.2) 207 (7.7) 46 (11.4) Alcohol consumption, n (%) 0.425 Never 2,776 (90.2) 2,404 (89.9) 372 (91.9) Former 222 (7.2) 199 (7.4) 23 (5.7) Current 81 (2.6) 71 (2.7) 10 (2.5) Anthropometrics Weight (kg) 42.0 (30.1, 54.5) 40.1 (29.1, 52.4) 56.7 (42, 74) < 0.001 Height (cm) 150.1 (135.2, 162.1) 150 (134.9, 162) 150.5 (137.7, 162.5) 0.160 BMI (kg/m2) 18.3 (16.0, 21.2) 17.6 (15.8, 20.0) 25.0 (22.0, 27.5) < 0.001 BMI-z 0.3 (−0.2, 1.0) 0.1 (−0.3, 0.7) 2.2 (1.8, 2.7) < 0.001 WC (cm) 63.4 (56.6, 71.2) 62.1 (55.8, 68.5) 79.5 (71.6, 88.1) < 0.001 WHtR 0.4 (0.4, 0.5) 0.4 (0.4, 0.5) 0.5 (0.5, 0.6) < 0.001 Abdominal obesity, n (%) 607 (19.7) 252 (9.4) 355 (87.7) < 0.001 Biochemistry Serum folate (ng/mL) 6.9 (4.7, 9.7) 6.9 (4.7, 9.8) 6.9 (5, 9.6) 0.812 Serum vitamin B12 (pg/mL) 554.4 (405.8, 729.1) 560 (408.4, 742.9) 524.7 (394.6, 676.9) 0.026 hs-CRP (mg/L) 0.3 (0.2, 0.8) 0.3 (0.2, 0.7) 0.9 (0.5, 2.2) < 0.001 eGFR (mL/min per 1.73 m2) 148.6 (135.2, 160.0) 148.0 (134.8, 159.3) 153.4 (139.1, 164) < 0.001 Note. Values are presented as median (interquartile range [IQR]) for continuous variables and n (%) for categorical variables. MVPA, total moderate-to-vigorous intensity physical activity; BMI, body mass index; BMI-z, BMI z-score; WC, waist circumference; WHtR, waist-to-height ratio; hs-CRP, high-sensitivity C-reactive protein; eGFR, estimated glomerular filtration rate. P-values were calculated using the Mann-Whitney U-test for continuous variables and the chi-square test for categorical variables. Table 2. Associations of serum folate and vitamin B12 concentrations with anthropometric indices among Chinese children and adolescents in Jiangsu Province, 2016–2017 (n = 3,079)
Micronutrient Model 1 Model 2 Model 3 Coefficient 95% Cl Coefficient 95% Cl Coefficient 95% Cl Serum folate (ng/mL) BMI −0.19 −0.45, 0.07 −0.23 −0.49, 0.03 0.09 −0.18, 0.35 BMI-z −0.06 −0.14, 0.01 −0.08 −0.15, 0.01 0.02 −0.06, 0.09 WC 0.39 −0.32, 1.10 −0.26 −0.96, 0.44 0.80 0.08, 1.52 WHtR 0.003 −0.001, 0.007 −0.001 −0.005, 0.003 0.004 0, 0.009 Serum vitamin B12 (pg/mL) BMI −0.83 −1.14, −0.53 −1.31 −1.61, −1.00 −1.34 −1.66, −1.01 BMI-z −0.24 −0.33, −0.15 −0.38 −0.47, −0.29 −0.38 −0.48, −0.29 WC −2.17 −3.00, −1.33 −4.23 −5.06, −3.39 −4.50 −5.37, −3.63 WHtR −0.011 −0.16, −0.006 −0.021 −0.026, −0.016 −0.023 −0.028, −0.018 Note. Model 1: adjusted for age, sex; Model 2: additionally adjusted for region, ethnicity, total energy intake, MVPA time, passive smoking status, alcohol consumption status, hs-CRP (log-transformed), eGFR (log-transformed), and multivitamin or B-vitamin supplement use. Model 3: additionally adjusted for vitamin B12(log-transformed) or serum folate (log-transformed) concentrations. MVPA, total moderate-to-vigorous intensity physical activity; BMI, Body mass index; BMI-z, BMI z-score; WC, waist circumference; WHtR, waist-to-height ratio; hs-CR, high-sensitivity C-reactive protein; eGFR, estimated glomerular filtration rate; CI,confidence interval. Serum folate and vitamin B12 were log-transformed. Table 3. Multivariable associations of serum folate and vitamin B12 levels with odds of general obesity and abdominal obesity among children and adolescents in Jiangsu Province, from 2016 to 2017 (n = 3,079)
Variables Model 1 Model 2 Model 3 OR (95% CI) OR (95% CI) OR (95% CI) Serum folate General obesity Continuous 0.96 (0.85, 1.08) 0.92 (0.81, 1.05) 1.02 (0.89, 1.17) Q1 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) Q2 1.17 (0.86, 1.60) 1.26 (0.91, 1.72) 1.44 (1.03, 2.00) Q3 1.00 (0.72, 1.39) 1.03 (0.73, 1.46) 1.22 (0.86, 1.74) Q4 0.91 (0.64, 1.28) 0.84 (0.58, 1.21) 1.08 (0.74, 1.59) P-trend 0.348 0.163 0.941 Abdominal obesity Continuous 0.98 (0.88, 1.09) 0.90 (0.81, 1.01) 1.00 (0.89, 1.13) Q1 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) Q2 1.06 (0.82, 1.38) 1.05 (0.80, 1.39) 1.21 (0.91, 1.60) Q3 0.90 (0.68, 1.18) 0.82 (0.61, 1.10) 0.98 (0.72, 1.32) Q4 0.94 (0.71, 1.25) 0.79 (0.58, 1.07) 1.02 (0.74, 1.40) P-trend 0.426 0.047 0.685 Serum vitamin B12 General obesity Continuous 0.82 (0.73, 0.93) 0.68 (0.60, 0.78) 0.68 (0.59, 0.78) Q1 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) Q2 0.90 (0.67, 1.21) 0.72 (0.53, 0.99) 0.72 (0.52, 0.99) Q3 0.79 (0.58, 1.08) 0.61 (0.44, 0.86) 0.61 (0.43, 0.85) Q4 0.46 (0.32, 0.65) 0.29 (0.2, 0.43) 0.29 (0.20, 0.43) P-trend < 0.001 < 0.001 < 0.001 Abdominal obesity Continuous 0.83 (0.75, 0.92) 0.68 (0.61, 0.76) 0.68 (0.60, 0.77) Q1 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) Q2 0.86 (0.67, 1.11) 0.67 (0.51, 0.87) 0.67 (0.51, 0.88) Q3 0.83 (0.64, 1.08) 0.63 (0.47, 0.83) 0.63 (0.47, 0.85) Q4 0.56 (0.42, 0.75) 0.36 (0.26, 0.49) 0.36 (0.26, 0.50) P-trend < 0.001 < 0.001 < 0.001 Note. The quartiles of serum folate concentration were as follows: < 4.7 ng/mL (Q1), 4.7–6.8 (Q2), 6.9–9.6 (Q3), and ≥ 9.7 (Q4). The quartiles of serum vitamin B12 concentrations were as follows: < 405.4 pg/mL (Q1), 405.4–554.1 (Q2), 554.2–728.8 (Q3), and ≥ 728.9 (Q4). Model 1: adjusted for age, sex; Model 2: additionally adjusted for region, ethnicity, total energy intake, MVPA time, passive smoking status and alcohol consumption status, hs-CRP (log-transformed), eGFR (log-transformed) and multivitamin or B-vitamin supplements use; Model 3: additionally adjusted for vitamin B12 (log-transformed) or serum folate (log-transformed) concentrations. MVPA, total moderate-to-vigorous intensity physical activity; hs-CRP, high-sensitivity C-reactive protein; eGFR, estimated glomerular filtration rate; OR, odds ratio; CI, confidence interval. Serum folate and vitamin B12 levels were log-transformed and standardized by subtracting the mean and dividing it by the standard deviation. Table 4. Joint association of serum folate and vitamin B12 levels with general obesity and abdominal obesity among Chinese children and adolescents in Jiangsu Province, from 2016 to 2017 (n = 3,079)
Serum folate Serum vitamin B12 Low Moderate High General obesity Low 1.13 (0.74, 1.72) 0.80 (0.53, 1.21) 0.63 (0.27, 1.49) Moderate 1.63 (1.11, 2.40) 1.00 (ref.) 0.51 (0.34, 0.77) High 1.60 (0.75, 3.41) 0.93 (0.65, 1.34) 0.31 (0.19, 0.50) Abdominal obesity Low 1.43 (1.00, 2.03) 0.94 (0.66, 1.33) 0.77 (0.37, 1.59) Moderate 1.50 (1.07, 2.11) 1.00 (ref.) 0.60 (0.42, 0.85) High 2.06 (1.09, 3.91) 0.96 (0.70, 1.32) 0.46 (0.31, 0.67) Note. The categories “low” “moderate” and “high” serum folate levels were based to quartiles and defined as follows: ≤ 4.7 ng/mL (Q1), 4.8–9.7 ng/mL (Q2 and Q3) and > 9.8 ng/mL (Q4), respectively. The categories “low” “moderate” and “high” serum vitamin B12 levels were based to quartiles (Q) and defined as follows: ≤ 405.4 pg/mL (Q1), 405.4–728.7 ng/mL (Q2 and Q3) and > 728.8 ng/mL (Q4), respectively. Model adjusted for age, sex, region, ethnicity, total energy intake, MVPA time, multivitamin or B-vitamin supplement use, hs-CRP level (log-transformed), eGFR (log-transformed), passive smoking status, and alcohol consumption status.MVPA, total moderate-to-vigorous intensity physical activity; hs-CRP, high-sensitivity C-reactive protein; eGFR, estimated glomerular filtration rate. -
[1] NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet, 2017; 390, 2627−42. doi: 10.1016/S0140-6736(17)32129-3 [2] WHO. Obesity and overweight. Geneva: WHO, 2021. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. [2020-4-1]. [3] Dong YH, Lau PWC, Dong B, et al. Trends in physical fitness, growth, and nutritional status of Chinese children and adolescents: a retrospective analysis of 1·5 million students from six successive national surveys between 1985 and 2014. Lancet Child Adolesc Health, 2019; 3, 871−80. doi: 10.1016/S2352-4642(19)30302-5 [4] García OP, Long KZ, Rosado JL. Impact of micronutrient deficiencies on obesity. Nutr Rev, 2009; 67, 559−72. doi: 10.1111/j.1753-4887.2009.00228.x [5] Thomas-Valdés S, Tostes MDGV, Anunciação PC, et al. Association between vitamin deficiency and metabolic disorders related to obesity. Crit Rev Food Sci Nutr, 2017; 57, 3332−43. doi: 10.1080/10408398.2015.1117413 [6] Lyon P, Strippoli V, Fang B, et al. B vitamins and one-carbon metabolism: implications in human health and disease. Nutrients, 2020; 12, 2867. doi: 10.3390/nu12092867 [7] Finer S, Saravanan P, Hitman G, et al. The role of the one-carbon cycle in the developmental origins of type 2 diabetes and obesity. Diabet Med, 2014; 31, 263−72. doi: 10.1111/dme.12390 [8] Ullegaddi R, Powers HJ, Gariballa SE. B-group vitamin supplementation mitigates oxidative damage after acute ischaemic stroke. Clin Sci (Lond), 2004; 107, 477−84. doi: 10.1042/CS20040134 [9] Li Z, Gueant-Rodriguez RM, Quilliot D, et al. Folate and vitamin B12 status is associated with insulin resistance and metabolic syndrome in morbid obesity. Clin Nutr, 2018; 37, 1700−6. doi: 10.1016/j.clnu.2017.07.008 [10] Kaya C, Cengiz SD, Satıroğlu H. Obesity and insulin resistance associated with lower plasma vitamin B12 in PCOS. Reprod Biomed Online, 2009; 19, 721−6. doi: 10.1016/j.rbmo.2009.06.005 [11] Chan CW, Chan PH, Lin BF. Folate deficiency increased lipid accumulation and leptin production of adipocytes. Front Nutr, 2022; 9, 852451. doi: 10.3389/fnut.2022.852451 [12] Chen S, Yang MY, Wang R, et al. Suppression of high-fat-diet-induced obesity in mice by dietary folic acid supplementation is linked to changes in gut microbiota. Eur J Nutr, 2022; 61, 2015−31. doi: 10.1007/s00394-021-02769-9 [13] Kumar KA, Lalitha A, Pavithra D, et al. Maternal dietary folate and/or vitamin B12 restrictions alter body composition (adiposity) and lipid metabolism in Wistar rat offspring. J Nutr Biochem, 2013; 24, 25−31. doi: 10.1016/j.jnutbio.2012.01.004 [14] Gallistl S, Sudi K, Mangge H, et al. Insulin is an independent correlate of plasma homocysteine levels in obese children and adolescents. Diabetes Care, 2000; 23, 1348−52. doi: 10.2337/diacare.23.9.1348 [15] Pinhas-Hamiel O, Doron-Panush N, Reichman B, et al. Obese children and adolescents: a risk group for low vitamin B12 concentration. Arch Pediatr Adolesc Med, 2006; 160, 933−6. [16] Gunanti IR, Marks GC, Al-Mamun A, et al. Low serum vitamin B-12 and folate concentrations and low thiamin and riboflavin intakes are inversely associated with greater adiposity in Mexican American children. J Nutr, 2014; 144, 2027−33. doi: 10.3945/jn.114.201202 [17] Brasileiro RS, Escrivão MA, Taddei JA, et al. Plasma total homocysteine in Brazilian overweight and non-overweight adolescents: a case-control study. Nutr Hosp, 2005; 20, 313−9. [18] Paul L, Selhub J. Interaction between excess folate and low vitamin B12 status. Mol Aspects Med, 2017; 53, 43−7. doi: 10.1016/j.mam.2016.11.004 [19] Yajnik CS, Deshpande SS, Jackson AA, et al. Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study. Diabetologia, 2008; 51, 29−38. doi: 10.1007/s00125-007-0793-y [20] Zhu QR, Dai Y, Zhang JX, et al. Association between serum zinc concentrations and metabolic risk factors among Chinese children and adolescents. Br J Nutr, 2021; 126, 1529−36. doi: 10.1017/S0007114521000258 [21] Zhang J, Wang DT, Eldridge AL, et al. Urban-rural disparities in energy intake and contribution of fat and animal source foods in Chinese children aged 4-17 years. Nutrients, 2017; 9(5): 526. [22] Li H, Zong XN, Ji CY, et al. Body mass index cut-offs for overweight and obesity in Chinese children and adolescents aged 2-18 years. Article in Chinese. Chin J Epidemiol, 2010; 31, 616−20. (In Chinese [23] National Health and Family Planning Commission of PRC. WS/T 586-2018 Screening for overweight and obesity among school-age children and adolescents. Beijing: Standards Press of China, 2018. (In Chinese [24] Dong B, Wang ZQ, Arnold LW, et al. Simplifying the screening of abdominal adiposity in Chinese children with waist-to-height ratio. Am J Hum Biol, 2016; 28, 945−9. doi: 10.1002/ajhb.22894 [25] Zhao WH, Huang ZP, Zhang X, et al. Reproducibility and validity of a Chinese food frequency questionnaire. Biomed Environ Sci, 2010; 23 Suppl, 1-38. [26] Yang YX, Wang GY, Pan XC. China food composition. 2nd ed. Peking University Medical Press. 2009. (In Chinese [27] Boutelle KN, Rhee KE, Liang JE, et al. Effect of attendance of the child on body weight, energy intake, and physical activity in childhood obesity treatment: a randomized clinical trial. JAMA Pediatr, 2017; 171, 622−8. doi: 10.1001/jamapediatrics.2017.0651 [28] Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med, 2009; 150, 604−12. doi: 10.7326/0003-4819-150-9-200905050-00006 [29] Cole TJ, Bellizzi MC, Flegal KM, et al. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ, 2000; 320, 1240−3. doi: 10.1136/bmj.320.7244.1240 [30] Mei H, Guo SY, Lu HY, et al. Impact of parental weight status on children's body mass index in early life: evidence from a Chinese cohort. BMJ Open, 2018; 8, e018755. doi: 10.1136/bmjopen-2017-018755 [31] Riso EM, Kull M, Mooses K, et al. Physical activity, sedentary time and sleep duration: associations with body composition in 10-12-year-old Estonian schoolchildren. BMC Public Health, 2018; 18, 496. doi: 10.1186/s12889-018-5406-9 [32] Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr, 1997; 65, 1220S−8S. doi: 10.1093/ajcn/65.4.1220S [33] Poorolajal J, Sahraei F, Mohamdadi Y, et al. Behavioral factors influencing childhood obesity: a systematic review and meta-analysis. Obes Res Clin Pract, 2020; 14, 109−18. doi: 10.1016/j.orcp.2020.03.002 [34] Samson ME, Yeung LF, Rose CE, et al. Vitamin B-12 malabsorption and renal function are critical considerations in studies of folate and vitamin B-12 interactions in cognitive performance: NHANES 2011-2014. Am J Clin Nutr, 2022; 116, 74−85. doi: 10.1093/ajcn/nqac065 [35] Hinnouho GM, Hampel D, Shahab-Ferdows S, et al. Daily supplementation of a multiple micronutrient powder improves folate but not thiamine, riboflavin, or vitamin B12 status among young Laotian children: a randomized controlled trial. Eur J Nutr, 2022; 61, 3423−35. doi: 10.1007/s00394-022-02890-3 [36] Sun YB, Sun MX, Liu BY, et al. Inverse association between serum vitamin B12 concentration and obesity among adults in the United States. Front Endocrinol (Lausanne), 2019; 10, 414. doi: 10.3389/fendo.2019.00414 [37] Knight BA, Shields BM, Brook A, et al. Lower circulating B12 is associated with higher obesity and insulin resistance during pregnancy in a non-diabetic white British population. PLoS One, 2015; 10, e0135268. doi: 10.1371/journal.pone.0135268 [38] Sukumar N, Venkataraman H, Wilson S, et al. Vitamin B12 status among pregnant women in the UK and its association with obesity and gestational diabetes. Nutrients, 2016; 8, 768. doi: 10.3390/nu8120768 [39] Krishnaveni GV, Hill JC, Veena SR, et al. Low plasma vitamin B12 in pregnancy is associated with gestational 'diabesity' and later diabetes. Diabetologia, 2009; 52, 2350−8. doi: 10.1007/s00125-009-1499-0 [40] Wiebe N, Field CJ, Tonelli M. A systematic review of the vitamin B12, folate and homocysteine triad across body mass index. Obes Rev, 2018; 19, 1608−18. doi: 10.1111/obr.12724 [41] Mahabir S, Ettinger S, Johnson L, et al. Measures of adiposity and body fat distribution in relation to serum folate levels in postmenopausal women in a feeding study. Eur J Clin Nutr, 2008; 62, 644−50. doi: 10.1038/sj.ejcn.1602771 [42] Bradbury KE, Williams SM, Mann JI, et al. Estimation of serum and erythrocyte folate concentrations in the New Zealand adult population within a background of voluntary folic acid fortification. J Nutr, 2014; 144, 68−74. doi: 10.3945/jn.113.182105 [43] Mlodzik-Czyzewska MA, Malinowska AM, Chmurzynska A. Low folate intake and serum levels are associated with higher body mass index and abdominal fat accumulation: a case control study. Nutr J, 2020; 19, 53. doi: 10.1186/s12937-020-00572-6 [44] Kancherla V, Botto LD, Rowe LA, et al. Preventing birth defects, saving lives, and promoting health equity: an urgent call to action for universal mandatory food fortification with folic acid. Lancet Glob Health, 2022; 10, e1053−7. doi: 10.1016/S2214-109X(22)00213-3 [45] Zheng LD, Linarelli LE, Liu LH, et al. Insulin resistance is associated with epigenetic and genetic regulation of mitochondrial DNA in obese humans. Clin Epigenetics, 2015; 7, 60. doi: 10.1186/s13148-015-0093-1 [46] Selhub J, Miller JW, Troen AM, et al. Perspective: the high-folate-low-vitamin B-12 interaction is a novel cause of vitamin B-12 depletion with a specific etiology-a hypothesis. Adv Nutr, 2022; 13, 16−33. doi: 10.1093/advances/nmab106 [47] He YN, Zhao WH, Zhang J, et al. Data resource profile: China national nutrition surveys. Int J Epidemiol, 2019; 48, 368-f.